#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Homocystinuria Anaplastic thyroid cancer Anal cancer Bronchopulmonary aspergillosis Pouchitis Huntington's disease Vascular malformation Adenoid cystic carcinoma Systemic mastocytosis Mixed-type liposarcoma Hyperoxaluria Peritoneal mesothelioma malignant Arterial tortuosity syndrome Acute on chronic liver failure Oesophageal squamous cell carcinoma stage III More trials…

    Learn about Rare Diseases

    Hepatic angiosarcoma – Trials in Disease Activated PI3 kinase delta syndrome – Life with Disease Familial amyotrophic lateral sclerosis Pemphigoid – Life with Disease Metachromatic leukodystrophy – Trials in Disease Atypical teratoid/rhabdoid tumour of CNS – Life with Disease X-linked lymphoproliferative syndrome – Trials in Disease Encephalitis autoimmune Phenylketonuria – Life with Disease Pleomorphic leiomyosarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ecoo16 Vortioxetine Hydrobromide Tryptophan Metoprolol Tartrate Anv600 Bortezomib ANTIMETABOLITES Icatibant Propranolol Hydrochloride Vericiguat Fluvastatin Topotecan Hydrochloride Ag13909 Vinorelbine REGN7544 Imipramine Hydrochloride Voclosporin Tomligisiran Indocyanine Green Zamtocabtagene Autoleucel More therapies…

    Learn about Your Condition

    Genitourinary tract neoplasm Thrombosis Osteomyelitis Ependymoma malignant Cytomegalovirus infection Radicular pain Hepatic cancer Staphylococcal bacteraemia Meniscus operation Vomiting Femoral neck fracture Mite allergy Colorectal cancer stage II Arrhythmia Sinus rhythm More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of Ruxolitinib and Venetoclax for Children with Relapsed or Refractory Leukemia or Lymphoma with IL-7R/JAK-STAT Pathway Mutations

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Precursor T-lymphoblastic lymphoma/leukaemia recurrent
    • Precursor T-lymphoblastic lymphoma/leukaemia refractory
    • Precursor B-lymphoblastic lymphoma recurrent
    Investigated Drugs:
    • Ruxolitinib
    • Venetoclax
    Austria Belgium Denmark Finland France Germany +5

  • Comparison of hydrocortisone and dexamethasone eye drops for treating inflammatory conjunctival secretions in patients with ocular prostheses

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Povidone
    • Hydrocortisone Sodium Phosphate
    • Dexamethasone Phosphate
    France

  • Study on Optimal Dose of Rabbit Anti-Human T-Lymphocyte Immunoglobulin and Mycophenolic Acid for Kidney Transplant Patients with Low Immunological Risk

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Renal failure
    • Renal transplant
    Investigated Drugs:
    • Mycophenolic Acid
    France

  • Study of acetylsalicylic acid to prevent stroke in patients undergoing brain aneurysm coiling procedure

    Recruiting

    3 1 1
    Investigated Diseases:
    • Intracranial aneurysm
    Investigated Drugs:
    • Lactose Monohydrate
    • Acetylsalicylic Acid
    France

  • Study on the Safety of ELGN-2112 for Preterm Infants with Intestinal Malabsorption

    Recruiting

    3 1
    Investigated Drugs:
    • Insulin Human
    Austria France Italy The Netherlands Spain Sweden

  • Study on the Effectiveness and Safety of Etanercept for Patients with SAPHO Syndrome

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • SAPHO syndrome
    Investigated Drugs:
    • Water For Injections
    • Etanercept
    Poland
Previous Page
1 … 397 398 399 400 401 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!